These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

502 related items for PubMed ID: 21762500

  • 1. Asthma control in patients receiving inhaled corticosteroid and long-acting beta2-agonist fixed combinations. A real-life study comparing dry powder inhalers and a pressurized metered dose inhaler extrafine formulation.
    Müller V, Gálffy G, Eszes N, Losonczy G, Bizzi A, Nicolini G, Chrystyn H, Tamási L.
    BMC Pulm Med; 2011 Jul 15; 11():40. PubMed ID: 21762500
    [Abstract] [Full Text] [Related]

  • 2. An innovative corticosteroid/long-acting β2-agonist breath-triggered inhaler: facilitating lung delivery of fluticasone propionate/formoterol fumarate for the treatment of asthma.
    Usmani O, Roche N, Marshall J, Danagher H, Price D.
    Expert Opin Drug Deliv; 2019 Dec 15; 16(12):1367-1380. PubMed ID: 31752560
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Comparing the efficacy and safety of formoterol/budesonide pMDI versus its mono-components and other LABA/ICS in patients with asthma.
    Mukhopadhyay A, Waked M, Gogtay J, Gaur V.
    Respir Med; 2020 Dec 15; 170():106055. PubMed ID: 32843176
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Comparison of extrafine beclomethasone dipropionate/formoterol fumarate dry powder inhaler and pressurized metered-dose inhaler in Chinese patients with asthma: the FORTUNE study.
    Zheng J, Zhang J, Fu X, Lin C, Zhang X, Mei X, Corradi M, Cappellini G, Calabro E, Zhu C, Topole E.
    J Asthma; 2024 Apr 15; 61(4):360-367. PubMed ID: 37878325
    [Abstract] [Full Text] [Related]

  • 13. Efficacy and safety of budesonide and formoterol in one pressurised metered-dose inhaler in adults and adolescents with moderate to severe asthma: a randomised clinical trial.
    Noonan M, Rosenwasser LJ, Martin P, O'Brien CD, O'Dowd L.
    Drugs; 2006 Apr 15; 66(17):2235-54. PubMed ID: 17137405
    [Abstract] [Full Text] [Related]

  • 14. Comparing the efficacy and safety of salmeterol/fluticasone pMDI versus its mono-components, other LABA/ICS pMDIs and salmeterol/fluticasone Diskus in patients with asthma.
    Mehta N, Aggarwal B, Gogtay J, Abdool-Gaffar S.
    Expert Opin Drug Deliv; 2015 Jun 15; 12(6):963-75. PubMed ID: 25429610
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Comparison of the effect of beclometasone/formoterol in asthma patients after methacholine-induced bronchoconstriction: A noninferiority study using metered dose vs. dry powder inhaler.
    Singh D, van den Berg F, Leaker B, Corradi M, Jabbal S, Collarini S, Mongelli V, Santoro L, Piccinno A, Biondaro S, Lipworth B.
    Br J Clin Pharmacol; 2019 Apr 15; 85(4):729-736. PubMed ID: 30586199
    [Abstract] [Full Text] [Related]

  • 17. Does Changing Inhaler Device Impact Real-Life Asthma Outcomes? Clinical and Economic Evaluation.
    Rhee CK, van Boven JFM, Yau Ming SW, Park HY, Kim DK, Park HS, Ling JZJ, Yoo KH, Price DB.
    J Allergy Clin Immunol Pract; 2019 Mar 15; 7(3):934-942. PubMed ID: 30292924
    [Abstract] [Full Text] [Related]

  • 18. Comparative Safety and Effectiveness of Inhaled Corticosteroid and Long-Acting β2-Agonist Combinations in Patients With COPD.
    Chang TY, Chien JY, Wu CH, Dong YH, Lin FJ.
    Chest; 2020 May 15; 157(5):1117-1129. PubMed ID: 31887282
    [Abstract] [Full Text] [Related]

  • 19. Extrafine HFA-beclomethasone-formoterol vs. nonextrafine combination of an inhaled corticosteroid and a long acting β2-agonist in patients with persistent asthma: A systematic review and meta-analysis.
    Liu T, Yang D, Liu C.
    PLoS One; 2021 May 15; 16(9):e0257075. PubMed ID: 34478483
    [Abstract] [Full Text] [Related]

  • 20. Differences in health care outcomes between postdischarge COPD patients treated with inhaled corticosteroid/long-acting β2-agonist via dry-powder inhalers and pressurized metered-dose inhalers.
    Wittbrodt ET, Millette LA, Evans KA, Bonafede M, Tkacz J, Ferguson GT.
    Int J Chron Obstruct Pulmon Dis; 2019 May 15; 14():101-114. PubMed ID: 30613140
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.